Literature DB >> 25044007

Comparing translational population-PBPK modelling of brain microdialysis with bottom-up prediction of brain-to-plasma distribution in rat and human.

Kathryn Ball1, François Bouzom, Jean-Michel Scherrmann, Bernard Walther, Xavier Declèves.   

Abstract

The prediction of brain extracellular fluid (ECF) concentrations in human is a potentially valuable asset during drug development as it can provide the pharmacokinetic input for pharmacokinetic-pharmacodynamic models. This study aimed to compare two translational modelling approaches that can be applied at the preclinical stage of development in order to simulate human brain ECF concentrations. A population-PBPK model of the central nervous system was developed based on brain microdialysis data, and the model parameters were translated to their corresponding human values to simulate ECF and brain tissue concentration profiles. In parallel, the PBPK modelling software Simcyp was used to simulate human brain tissue concentrations, via the bottom-up prediction of brain tissue distribution using two different sets of mechanistic tissue composition-based equations. The population-PBPK and bottom-up approaches gave similar predictions of total brain concentrations in both rat and human, while only the population-PBPK model was capable of accurately simulating the rat ECF concentrations. The choice of PBPK model must therefore depend on the purpose of the modelling exercise, the in vitro and in vivo data available and knowledge of the mechanisms governing the membrane permeability and distribution of the drug.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  CNS; PBPK; microdialysis; modelling; translational

Mesh:

Substances:

Year:  2014        PMID: 25044007     DOI: 10.1002/bdd.1908

Source DB:  PubMed          Journal:  Biopharm Drug Dispos        ISSN: 0142-2782            Impact factor:   1.627


  8 in total

Review 1.  Treating disorders of the neonatal central nervous system: pharmacokinetic and pharmacodynamic considerations with a focus on antiepileptics.

Authors:  Maria D Donovan; Geraldine B Boylan; Deirdre M Murray; John F Cryan; Brendan T Griffin
Journal:  Br J Clin Pharmacol       Date:  2015-11-04       Impact factor: 4.335

Review 2.  Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation Approaches: A Systematic Review of Published Models, Applications, and Model Verification.

Authors:  Jennifer E Sager; Jingjing Yu; Isabelle Ragueneau-Majlessi; Nina Isoherranen
Journal:  Drug Metab Dispos       Date:  2015-08-21       Impact factor: 3.922

3.  Assessment of DCE-MRI parameters for brain tumors through implementation of physiologically-based pharmacokinetic model approaches for Gd-DOTA.

Authors:  Marios Spanakis; Eleftherios Kontopodis; Sophie Van Cauter; Vangelis Sakkalis; Kostas Marias
Journal:  J Pharmacokinet Pharmacodyn       Date:  2016-09-19       Impact factor: 2.745

4.  Reduced Systemic and Brain Exposure with Inhibited Liver Metabolism of Carbamazepine After Its Long-Term Combination Treatment with Piperine for Epilepsy Control in Rats.

Authors:  Tianjing Ren; Min Xiao; Mengbi Yang; Jiajia Zhao; Yufeng Zhang; Mengyun Hu; Yan Cheng; Hong Xu; Chunbo Zhang; Xiaoyu Yan; Zhong Zuo
Journal:  AAPS J       Date:  2019-07-18       Impact factor: 4.009

Review 5.  In Vitro to In Vivo Extrapolation Linked to Physiologically Based Pharmacokinetic Models for Assessing the Brain Drug Disposition.

Authors:  Yukiko Murata; Sibylle Neuhoff; Amin Rostami-Hodjegan; Hiroyuki Takita; Zubida M Al-Majdoub; Kayode Ogungbenro
Journal:  AAPS J       Date:  2022-01-13       Impact factor: 4.009

6.  Application of Physiologically Based Pharmacokinetic Modeling in Preclinical Studies: A Feasible Strategy to Practice the Principles of 3Rs.

Authors:  Yawen Yuan; Qingfeng He; Shunguo Zhang; Min Li; Zhijia Tang; Xiao Zhu; Zheng Jiao; Weimin Cai; Xiaoqiang Xiang
Journal:  Front Pharmacol       Date:  2022-05-12       Impact factor: 5.988

Review 7.  Recent developments in using mechanistic cardiac modelling for drug safety evaluation.

Authors:  Mark R Davies; Ken Wang; Gary R Mirams; Antonello Caruso; Denis Noble; Antje Walz; Thierry Lavé; Franz Schuler; Thomas Singer; Liudmila Polonchuk
Journal:  Drug Discov Today       Date:  2016-02-15       Impact factor: 7.851

8.  A Generic Multi-Compartmental CNS Distribution Model Structure for 9 Drugs Allows Prediction of Human Brain Target Site Concentrations.

Authors:  Yumi Yamamoto; Pyry A Välitalo; Dirk-Jan van den Berg; Robin Hartman; Willem van den Brink; Yin Cheong Wong; Dymphy R Huntjens; Johannes H Proost; An Vermeulen; Walter Krauwinkel; Suruchi Bakshi; Vincent Aranzana-Climent; Sandrine Marchand; Claire Dahyot-Fizelier; William Couet; Meindert Danhof; Johan G C van Hasselt; Elizabeth C M de Lange
Journal:  Pharm Res       Date:  2016-11-18       Impact factor: 4.200

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.